August 27, 2014 | Teva Pharmaceuticals and Indian company Venus Remedies entered into a collaborative agreement for the sale of an anti-cancer drug in the Canadian market. According to the agreement, Venus Remedies will manufacture the drug and will assist Teva in registering the drug in Canada. Venus will also use its manufacturing capabilities to support Teva enhance its business in the Canadian market. Teva is an international pharmaceutical company headquartered in Petah Tikvah, Israel, founded in 1901.
Related posts
Red Algae Can Treat Wounds And Infections
January 26, 2023
Freight Planner Lists on Nasdaq And Raises $80M
January 26, 2023
$6M Investment For “Lettuce Milk” Startup
January 25, 2023
Israel Has World’s Best Value Internet
January 25, 2023
Facebook comments